GENZ Related Insiders' Blog
-
Raised Bid for Genzyme (GENZ) Could Be Coming as Sanofi (SNY) Scrounging for More Financing
-
Wall Street Hubbub 8/31: Saks In the Crosshairs, JPMorgan To Close Prop-Trading, Dean Foods Takeover Chatter, Dell Up To Bat on 3PAR
-
Wall Street Hubbub 8/30: A Higher Bid for Genzyme, Cisco After Skype, EMC Could Be a Takeover Target
-
Shareholders: Thanks For the Offer, But We Want More
-
Relational Investors 13F Shows Switches in Some Sectors, New Stake in SPDRs (SPY, MET, ALL, CRL, More...)
-
Wall Street Hubbub 8/16: 13F Season, 3Par/Dell Deal Sparks Chatter, What About Genzyme?
-
Carl Icahn Shows New Stakes In Energy Names and a Gun Maker (APC, NRG, SWHC)
-
Wall Street Hubbub 8/10: A Replacement for Hurd?; Larry to the Rescue; Genzyme (GENZ) Dragging Its Feet
-
Wall Street Hubbub 8/03: Is Goldman Spinning Its PE Unit, Sanofi/Genzyme In a Standstill On Price Already, a Hedge Fund Merger
-
Wall Street Hubbub 8/2: HGSI and MJN Seen As Targets, Layoffs at Barclays?, Goldman Sachs Ticks Off New Neighbors
-
Wall Street Hubbub 7/29: A CSCO-Sized Fat Finger; Formal Bid for Genzyme Coming, No More "Sh---- Deals" For Goldman (GS), U.S. On Verge of Japanese-Style Deflation
-
Wall Street Hubbub 7/26: A Genzyme (GENZ) Deal Coming, Is Biogen Idec (BIIB) Next, New BP CEO, Goldman Sachs the Movie
-
Wall Street Aflutter With Genzyme (GENZ) Takeover Speculation
-
Genzyme (GENZ) Creeps Higher On Potential Biotech Mega-Deal
-
Relational Investors Builds Stakes In Deere (DE) and Progress Software (PRGS), Cuts Home Depot (HD)
-
Icahn Lowers Stakes In CIT, BBI, YHOO; Raises Stakes in TTWO, GENZ and MOT; New Stake in CHK
-
'Takeover Fever' Continues In Biotech After Facet (FACT) Deal, Who's Next?
-
Carl Icahn Raises Stakes In Take-Two (TTWO) and Genzyme (GENZ), Slashes Stake in Yahoo! (YHOO)
-
Morgan Stanley Gives a Preview for Biotech's Q4 Earnings (GILD, CELG, BIIB, GENZ, More...)
-
Carl Icahn Takes a Stab At Beaten-Up Genzyme (GENZ), Can He Spark a Rally
-
FDA Warns Doctors of Contamination at Genzyme (GENZ) Plant; Stock Tumbles
-
Goldman Sachs Says FDA News on Genzyme (GENZ) is a "Significant Negative Surprise"
-
Stocks That Could Rise As Cases Of The Swine Flu Increase (RAD, GENZ, GILD, UTHR, XRAY)
-
Protalix BioTherapeutics (PLX) Gets Huge Opportunity Due To Genzyme's (GENZ) Plant Shut-Down
-
Article Speculates AMAG Pharmaceuticals (AMAG) Could Be A Takeover Target
-
Genzyme (GENZ) Sinks After Interrupting Production at Allston Plant
-
Relational Investors Raises Stake in Genzyme (GENZ), Shows New Stakes in Occidental Pet (OXY) and Freeport-McMoRan (FCX)
-
Baird Said a Genzyme (GENZ) Takeover Of BioMarin (BMRN) Makes Sense To Them
-
Relational Investors Discloses Hidden Stakes in Plantronics (PLAB), Burlington Northern (BNI), Genzyme (GENZ) and Zebra Tech (ZBRA)
-
Big Biotech a Safe Haven? AMGN Moves Higher
-
Potential Bounce Candidates: NVDA, INTC, GENZ, UBS, LIZ
-
Summary of Icahn Capital 13F; New Stake In JCP, Ups Stakes in APC, M
-
C.R. Bard (BCR) Breaks Out to New All-Time High
-
Icahn's Hedge Fund Shows New Stakes In Genzyme (GENZ) and Childrens Place (PLCE), Among Others
Back to GENZ Stock Lookup
